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The comet assay has become a popular method for the
assessment of DNA damage in biomonitoring studies and
genetic toxicology. However, few studies have addressed
the issue of the noted inter-laboratory variability of DNA
damage measured by the comet assay. In this study, 12
laboratories analysed the level of DNA damage in mono-
cyte-derived THP-1 cells by either visual classification or
computer-aided image analysis of pre-made slides, coded
cryopreserved samples of cells and reference standard cells
(calibration curve samples). The reference standard
samples were irradiated with ionizing radiation (0–10
Gy) and used to construct a calibration curve to calculate
the number of lesions per 106 base pair. All laboratories
detected dose–response relationships in the coded samples
irradiated with ionizing radiation (1.5–7 Gy), but there
were overt differences in the level of DNA damage
reported by the different laboratories as evidenced by an
inter-laboratory coefficient of variation (CV) of 47%.
Adjustment of the primary comet assay end points by
a calibration curve prepared in each laboratory reduced
the CV to 28%, a statistically significant reduction (P <
0.05, Levene’s test). A large fraction of the inter-laboratory
variation originated from differences in image analysis,
whereas the intra-laboratory variation was considerably
smaller than the variation between laboratories. In
summary, adjustment of primary comet assay results by
reference standards reduces inter-laboratory variation in
the level of DNA damage measured by the alkaline version
of the comet assay.
Introduction
The comet assay, also known as the single-cell gel electro-
phoresis assay, is a popular method in genetic toxicology and
biomonitoring studies for assessing and measuring DNA
damage at the level of individual cells. The damage detected
is commonly referred to as strand breaks, although the alkaline
version of the comet assay also detects alkali-labile sites and
transient breaks created during DNA repair processes. It is
probably the methodological simplicity of the comet assay, its
low material requirement and the ability to focus on the level of
damage in individual cells that are the main reasons for its
widespread use.
Although the comet assay procedure is relatively simple,
methodological differences exist and these have been discussed
extensively elsewhere (1,2). The key methodological steps of
the assay include (i) embedding single-cell suspensions in
agarose, (ii) lysis that removes cellular and nuclear membranes
and the majority of proteins, (iii) alkaline treatment,
(iv) electrophoresis and (v) staining of the DNA comets
formed. The extent of comet formation is visualized and
assessed by fluorescence microscopy. Several international
workgroups have made recommendations for the procedure
(3–6). These will most likely develop into official guidelines
issued, for instance, by the Organisation for Economic
Co-operation and Development. However, laboratories will
undoubtedly continue to use their own procedures and this will
contribute to inter-laboratory variation in the measurement of
DNA damage. Inter-laboratory differences can in principle be
reduced by including reference standards in the analysis.
However, these have not yet been developed for the comet
assay, although many laboratories prepare their own reference
standards as controls for intra-laboratory variation.
The expression of comet assay end points in different units
has made it problematic even to begin to address the variation
in DNA damage between laboratories. There are many ways of
measuring the level of DNA damage with the comet assay,
including continuous measurements (computerized scoring in
different units such as percent DNA in the tail (%T), tail length
and tail moment) and categorical measurements (visual scoring
in arbitrary units), as well as various descriptions of the
distribution of the images. DNA damage is often expressed as
tail moment, which essentially is the product of the length
and %T, although there are diverse formulae to calculate the
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tail moment. At least in theory, it should be possible to make
direct comparisons between laboratories using the same comet
assay end point, but in practice this has been much more
difficult than expected. It has been argued that the tail length is
a poor end point because it is only linear with respect to dose
within a narrow interval and the tail moment, although a valid
measure, was judged to be problematical because it is difficult
to visualize the appearance of the comets from tail moment
values (7). Alternatively, one could argue that the most
informative way of expressing comet assay results is as lesions
per unaltered nucleotides or base pairs (bp). This can be done
using a calibration curve determined by the dose–response
relationship of ionizing radiation. Using this approach, it has
been shown that intra-laboratory variation in DNA damage
could be slightly reduced when different investigators from the
same laboratory analysed the same samples (8,9). Previous
inter-laboratory studies on the comet assay have documented
a rather large variation (10–13). The European Standards
Committee on Oxidative DNA Damage (ESCODD) attempted
to decrease the variation using standardized methods and
parallel analysis of reference samples, although that trial did
not include laboratory-specific calibration curves. The aim of
the present study was to investigate the inter-laboratory
variation in DNA damage measured by the comet assay and
to assess the possibility of reducing it by calibration with
reference samples.
Materials and methods
Twelve laboratories participated in this inter-laboratory validation trial. All
samples were prepared at the University of Copenhagen and distributed to the
different laboratories as either pre-made slides or cryopreserved samples, the
latter consisting of calibration curve or coded samples. Each laboratory also
received a questionnaire to complete concerning its protocol for the comet
assay (Table I).
Analysis of DNA damage in pre-made slides of gel-embedded cells
The purpose of this part of the study was to assess the variation in the image
analysis of comet assay nucleoids. We used monocytic THP-1 cells from the
American Type Culture Collection (Manassas, VA, USA). These cells were
chosen because undamaged THP-1 cells have clear circular ‘comet’ images.
They were cultured in RPMI 1640 medium with 10% foetal bovine serum
(Invitrogen A/S, Ta˚strup, Denmark) and 1% penicillin–streptomycin solution
(the stock solution from Invitrogen A/S contains 10 000 units/ml of penicillin
G and 10 000 lg/ml of streptomycin in 0.85% saline). Cells were irradiated
with 0, 2.5, 5 or 10 Gy of c-rays from a Gamma Cell 2000 Cs137 source (dose
rate 3.77 Gy/min), suspended in phosphate-buffered saline (PBS). The cells
were irradiated in ice-cold PBS to avoid generation of DNA damage during the
subsequent processing of the cells.
The cells were processed by the alkaline comet assay in the same laboratory
that cultured and irradiated the cells. Briefly, THP-1 cells were embedded in
0.75% low-melting-point agarose (Sigma-Aldrich A/S, Brøndby, Denmark) on
GelBondfilms (Lonza Copenhagen ApS, Vallenbæk Strand, Denmark) and
lysed [1% Triton X-100, 2.5 M NaCl, 100 mM Na2 ethylenediaminetetraacetic
acid (EDTA), 10 mM Tris, pH 10] for a minimum of 1 h at 4C. The GelBond
films were then immersed in an alkaline solution (300 mM NaOH, 1 mM
Na2EDTA, pH 13) for 40 min and the duration of the subsequent
electrophoresis was 20 min in the same solution at 1.30 v/cm (voltage across
the platform) and 300 mA. After electrophoresis, the GelBond films were
washed thrice for 5 min in Tris buffer (0.4 M Tris-HCl, pH 7.5), rinsed with
milliQ water, dried in 96% ethanol and distributed to the 12 participating
laboratories by mail. The laboratories were instructed to stain the slides and
analyse the gel-embedded comets. Each of the four coded slides consisted of
nucleoids in two separate gels. We refer to these samples as pre-made slides in
this article.
Unknown cryopreserved samples A–D
THP-1 cells suspended in ice-cold PBS were irradiated with 1.5, 2.5, 5 or 7 Gy
of c-rays from a Cs137 source. The irradiated cells were then counted and
aliquots frozen in a mixture containing 50% foetal bovine serum, 40% culture
medium (RPMI 1640; Invitrogen) and 10% dimethylsulfoxide. Each
participating laboratory received the cryopreserved coded samples to be
analysed according to its own protocol.
Calibration curves
THP-1 cells suspended in ice-cold PBS were irradiated with 0, 2.5, 5 or 10 Gy
of c-rays from a Cs137 source. The irradiated cells were then counted and
aliquots frozen in a mixture containing 50% foetal bovine serum, 40% culture
medium (RPMI 1640) and 10% dimethylsulfoxide. Each participating
laboratory received the cryopreserved irradiated samples to be analysed
according to the same protocol and in the same run as the coded samples. The
laboratories obtained calibration curves by scoring slides of the 0-, 2.5-, 5- and
10-Gy irradiated THP-1 cells.
Reported end points
The laboratories reported the results in different primary comet assay end
points, i.e. %T, tail moment, tail length and visual score. Two laboratories only
reported data as %T because their software systems do not measure tail length
Table I. Assay conditions used by different laboratoriesa
Laboratory Agarose
(%)b
Alkali
(min)
Electrophoresis Nuclei scored/gel
(no. of gels/sample)
Staind Software
Current
(mA)
Voltage
(V)
Voltage/cm
(V/cm)c
Time
(min)
1 0.75 40 300 30 0.91 20 100 (4) YOYO-1 Comet IV (Perceptive Instruments)e
2 0.75 40 300 24 1.53 30 50 (3) EtBr Komet 4.0 (Kinetic Imaging Ltd)
3 0.65 20 300 25 0.90 20 50 (2) EtBr Comet III (Perceptive Instruments)e
4 0.65 20 300 22 1.48 24 50 (1) EtBr Comet IV (Perceptive Instruments)
5 0.75 40 300 25 1.30 20 100 (2) YOYO-1 Visual score
6 0.60 20 300 30 0.88 20 50 (4) PI Komet 5.5 (Kinetic Imaging Ltd)
7 1.00 40 260–300 25 1.60 30 30 (2) DAPIf Comet IV (Perceptive Instruments)
8 1.00 40 300 25 1.14 20 .50 (2) EtBr Cometa 1.5 (Immagini e Computer)e
9 1.00 20 300 25 0.76 30 50 (2) DAPI Lucia 4.61 (Precoptic C, Czech Republic)
10 0.80 40 300 23 1.24 20 50 (2) EtBr Komet 5.5 (Kinetic Imaging Ltd)
11 0.75 40 292–300 25 1.25 20 50 (2–3) SYBR Gold Komet 3.0 (Kinetic Imaging Ltd)
12 0.60 20 300 30 1.13 20 100 (1) EtBr Comet IV (Perceptive Instruments)
aAll laboratories used the same solution in the alkaline unwinding and electrophoresis of the comet assay (0.3 M NaOH, 1 mM EDTA, pH . 13).
bThe data represent the agarose density [% agarose in PBS or Tris base, acetic acid and EDTA (TAE)].
cThe values represent the voltage across the platform of the electrophoresis tank.
dThe dyes are 4#,6-diamidino-2-phenylindole (DAPI), ethidium bromide (EtBr), propidium iodide (PI) and YOYO-1 iodide (YOYO-1).
eThis laboratory also analysed the level of DNA damage in the pre-made slides by visual classification.
fThis laboratory used DAPI for the cryopreserved samples. However, the staining generated a large background signal on the pre-made slides (GelBonds). This
laboratory stained the pre-made slides with SYBR Gold.
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or tail moment. The visual score was calculated by classification of images in
five different categories (9). Usually, the visual score is reported in the range of
0–400 arbitrary units, but in this article, we convert the visual score to give
a range of 0–100 arbitrary units so that it is comparable with %T. This makes it
easier to compare the standard deviation (SD) between these end points. The
primary comet assay end points were converted to lesions per 106 bp by means
of the derived laboratory-specific calibration curves. We have used lesions per
106 bp as end point because the simple version of the comet assay, which is
used in this study, detects a broad range of nucleotide lesions. Alternatively, the
expression of the DNA damage as lesions per 109 dalton DNA is just as
informative, although the nominator and denominator have different units. It is
possible by calibration with ionizing radiation to transform primary comet
assay end points to lesions per 106 bp because there is well-established
relationship between the dose of ionizing radiation and yield of strand breaks in
DNA. The yield of strand breaks per Gy has been found to be 0.27 and 0.31
breaks/109 dalton using alkaline sucrose sedimentation technique in two
different studies, respectively (14,15); for our calibration, we have used the
average of these values (0.29 lesions/109 dalton DNA). Furthermore, we
assume that the average molecular weight of a DNA bp is 650 dalton. Based on
dose equivalence in the alkaline sucrose sedimentation technique and comet
assay, the slopes of the calibration curves (DNA damage/Gy) were used to
calculate how many lesions per 106 bp a particular level of DNA damage
corresponded to:
DNA damagesample
acalibration curve
 0:29
109
 650  106 5 number of lesions=106 bp
The ‘DNA damagesample’ is the primary comet assay end point, which can
be the visual score, %T, tail length or tail moment; the ‘acalibration curve’ is the
specific calibration curve that corresponds to the primary comet assay end
point.
The human genome contains 2.9  109 nucleotides (16), corresponding to
approximately 6  109 bp (or approximately 4  1012 dalton DNA) per diploid
cell in G0 phase. The THP-1 cells in our calibration curve samples contained
6  109 dalton DNA (the DNA content was measured in THP-1 cells using an
Eppendorf BioPhotometer). The DNA content of the THP-1 cells is somewhat
higher than the content of human diploid cells because it is a tetraploid cell line
(Japanese Collection of Research Bioresources; http://cellbank.nibio.go.jp/
celldata/jcrb0112.htm, search August 19, 2009) and we used proliferating cell
cultures.
Statistical analysis
All the statistical analyses were carried out by parametric tests using general
linear model (GLM), repeated measures analysis of variance (ANOVA) and
linear regression analysis (17). Differences in the distribution were assessed by
Levene’s test. In all the tests, the level of significance was 5%. The analyses
were carried out in Statistica version 5.5 for Windows (StatSoft, Inc., Tulsa,
OK, USA). The inter-laboratory variation in DNA damage is mainly assessed
as differences in SD of either the comet assay end points or the residuals
(SDres); this requires that the range in the data is the same. For this reason, we
have calculated secondary comet assay end points using common calibration
curves; these are generated as the mean of the laboratory-specific calibra-
tion curves. The data obtained from these calculations from common
calibration curves are referred to as adjusted data.
Results
Variation in DNA damage measured by analysis of pre-made
slides of gel-embedded comet nucleoids
The investigators in the different laboratories used different dyes
to stain the slides (Table I). The dyes were propidium iodide,
ethidium bromide, YOYO-1 iodide, SYBR Gold and 4#,6-
diamidino-2-phenylindole. In addition, the software systems
differed and a few laboratories used visual scoring (Table I).
Figure 1 shows the results obtained from the analysis of the
coded pre-made slides, which contained cells that had been
exposed to 0, 2.5, 5 or 10 Gy (examples of images recorded
from the staining of the slides in different laboratories are
available as supplementary data in Mutagenesis online). From
the results depicted in Figure 1, it can be seen that the tail
length data are rather poor, there is a large degree of variation
in the baseline levels of DNA damage (0 Gy) and the dose–
response relationships are poor. The data expressed as tail
moment are much better than tail length in terms of low
variation in the baseline level of DNA damage and dose–
response relationships. In fact, linear dose–response relation-
ships in terms of the tail moment (R2mean 5 0.94, SD 5 0.11)
and %T (R2mean 5 0.96, SD 5 0.04) were not significantly
different from each other (P 5 0.48, paired t test of regression
coefficients). The data expressed as visual score also increased
dose dependently, although the slopes decrease at high doses as
the assay reaches saturation.
Table II shows the mean level of DNA damage, SD and
coefficient of variation (CV) calculated as SD/mean in the pre-
made slides. Only the data expressed as arbitrary units (visual
score) and %T are shown because it is possible to compare
directly values of these end points. It can be seen that the CV
decreases as the level of DNA damage increases when assessed
as visual score. The same trend toward reduced CV is not as
obvious in the slides scored by software systems (%T). For both
the visual score and the %T data sets, the dose of ionizing
radiation accounted for most of the overall variation (84.9% and
67.2%, respectively). The inter-laboratory variation was 17.0%
for %T and 4.9% for visual scoring. However, it can also be seen
in Table II that for the same level of DNA damage (i.e. 35.5 for
visual scoring and 35.1 for %T), there were approximately the
same SD values (12.0 and 12.6, respectively), indicating that the
variation is the same for these end points at similar level of DNA
damage. Overall, these data indicate that the variation in DNA
damage measured by different laboratories is similar whether it
is analysed as %T by computerized scoring or as arbitrary units
by visual scoring. This means that neither of the end points
appears to be superior, although they both appear to be better
primary end points than the tail length.
Variation in DNA migration measured by analysis of
cryopreserved samples
Figure 2 depicts the results from the calibration curve samples
and the coded samples when the laboratories analysed
cryopreserved samples by their own comet assay protocols.
All 12 laboratories reported dose-dependent relationships
between the dose of ionizing radiation and the level of DNA
damage in both the cryopreserved calibration curve samples
and the coded samples when measured as %T or visual score
(P , 0.05, except in one laboratory where the linear
relationship of calibration curve samples was of borderline
statistical significance, P5 0.054, linear regression). As can be
seen in Figure 2, there was a huge variation in the values of
DNA damage obtained in different laboratories. This difference
could be due to different assay procedures; however, even if
this was the case, the relative level of DNA damage in the
calibration curve and coded samples within each laboratory
should be similar. The samples irradiated with 2.5 and 5 Gy
were included as both calibration curve samples and coded
samples. This means that differences between the samples
irradiated with 2.5 Gy (and 5 Gy) can only be explained by
variation between slides or bias in the analysis of uncoded
samples. The latter issue is a controversial issue in comet assay
analysis; it is hypothesized that knowledge about samples
might cause investigators unintentionally to select or omit
some images rather than to select them randomly. This bias is
omitted by coding the samples prior to analysis. Figure 3A
shows this relationship in the subset of the samples treated with
2.5 and 5 Gy. Samples irradiated with 5 Gy had—as
expected—significantly higher levels of DNA damage than
those irradiated with 2.5 Gy [P , 0.05, repeated measures
Inter-laboratory variation in DNA damage
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ANOVA with the sample (2.5 or 5 Gy) as categorical variable].
There was no significant difference between calibration curve
samples and the coded samples exposed to the same doses of
radiation. This indicates that the investigators were not biased
when scoring the calibration curve samples as compared with
the coded samples. Figure 3B shows the relationship between
the slopes obtained with the calibration curve samples and
those obtained with the coded samples; the difference
(calculated by subtracting the value of the slopes from each
other) between the slopes of the calibration curve and coded
samples from each laboratory did not depart significantly
from zero [delta valueslope 5 0.04, 95% confidence interval
(CI) 0.03 to 0.11)]. This analysis indicates that participants
did not treat the calibration curve and coded samples
differently, although there clearly is variation between
laboratories.
The total variation in the level of DNA damage in the
cryopreserved samples can be explained by the following
variables: the dose of ionizing radiation, different laboratory
procedures, different software systems and unexplained
variation (noise). This was assessed in a single-factor GLM
analysis with the level of DNA damage in the coded samples as
Table II. DNA damage measured in pre-made slides as visual score in
arbitrary units (a.u.) or %Ta
Dose of
ionizing
radiation (Gy)
Visual score (a.u.), n 5 4 %T, n 5 11
Mean (SD) CV (%) Mean (SD) CV (%)
0 2.7 (3.3) 136 3.9 (2.4) 61
2.5 35.5 (12.0) 34 17.2 (7.7) 45
5 64.8 (11.3) 17 35.1 (12.6) 36
10 82.9 (7.6) 9 51.9 (20.6) 40
aThe contribution of the inter-laboratory variation and the dose of ionizing
radiation to the overall variation was analysed by a GLM with the laboratory as
random categorical variable and the dose of ionizing radiation as continuous
variable. Statistical analysis of the visual score data set showed that the
variation attributed to the dose of ionizing radiation and inter-laboratory
variation explained 84.9% (P , 0.001) and 4.9% (P 5 0.21), respectively, of
the overall variation. The residual variation explained 10.2% of the overall
variation (SDres 5 10.4). GLM analysis of the %T data set showed that
the variation attributed to the dose of ionizing radiation and inter-laboratory
variation explained 67.2% (P , 0.001) and 15.6% (P , 0.01) of the
overall variation. The residual variation explained 17.0% of the overall
variation (SDres 5 9.1).
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dependent variable and the overall laboratory procedures
(categorical variable, n 5 12), dose of radiation (continuous
variable, n 5 4) and level of DNA damage in the pre-made
slides (continuous variable, n 5 4) as independent variables.
The contribution of the software systems to the overall
variation in DNA damage reported by different laboratories
can be estimated because the same samples of cells were used
for the coded cryopreserved samples and the pre-made slides.
This analysis showed that the laboratory procedures (F 5 5.2,
P , 0.001), dose of ionizing radiation (F 5 14.6, P , 0.001)
and the level of DNA damage in the pre-made slides (F 5 9.1,
P , 0.01) had statistically significant single-factor effects
and these variables explained the majority of the variation
(R2model 5 0.90, GLM analysis). Not surprisingly, the dose of
ionizing radiation was a strong predictor of the level of DNA
damage in the coded samples. However, differences in both
laboratory procedures and image analysis systems also
contributed significantly to the variation in the coded
cryopreserved samples. Figure 4 shows the relationship
between the level of DNA damage in the pre-made slides
and the cryopreserved samples derived from the exact same
exposure to ionizing radiation. The agarose density, duration of
the alkaline treatment and electrophoresis, and strength of the
electrophoretic field (V/cm) are considered to be the critical
parameters that will affect the migration of DNA in the comet
assay (outlined in Table I). However, we did not find clear
relationships between the agarose density, duration of the
alkaline treatment and electrophoresis, and strength of
the electrophoretic field (V/cm) in different laboratories
and the level of DNA damage [linear regression analysis with
the baseline (0 Gy) samples or the slope of the dose–response
curve as dependent variable]. Also, different combinations of
the four variables did not reveal any clear associations between
the assay conditions and level of DNA damage. It should be
emphasized that this analysis only implies that differences
between assay conditions were not strong enough to explain
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the differences of the level of DNA damage measured in
different laboratories. In addition, the statistical power of this
analysis was small considering that there were four variables
(assay conditions) and only 12 laboratories.
The variation attributed to different laboratory procedures
(inter-laboratory variation) and intra-laboratory variation can
be assessed by an analysis of the calibration curve samples that
were analysed in one to three separate experiments in the
different laboratories. The period between the first and last
experiment was about 6–10 months in each laboratory,
indicating that it should be possible to detect if there was
day-to-day variation. We did not attempt to standardize the
assay conditions in the laboratories during the period of the
trial; this probably means that a number of assay conditions
could have changed because of the new batches of chemicals
and because of possible changes in the intensity of the
fluorescent lamp in the microscopes. Ten laboratories analysed
calibration curve samples on two or three different occasions,
whereas two laboratories only analysed the calibration curve
samples in one experiment. Table III outlines the statistical
analysis of the data; in this analysis, the intra-laboratory
variation is the same as the day-to-day variation and the
residual variation is the unexplained variation. It is obvious that
the dose of ionizing radiation explains most of the variation,
whereas the magnitude of the residual variation is larger than
the day-to-day variation.
Level of DNA damage in cryopreserved samples expressed as
lesions per 106 bp
Figure 5 shows the number of lesions per 106 bp in the coded
samples that represented cells that had been irradiated with 1.5,
2.5, 5 or 7 Gy of ionizing radiation. All laboratories reported the
same ranking of the four coded samples (results not shown); this
ranking was in accordance with the dose of ionizing radiation.
The mean linear regression coefficient (R2) for all laboratories
was 0.97 (range 0.89–0.99). It can be seen in Figure 5 that the
CV is reduced as the level of DNA damage increases.
The calibration curve generated by ESCODD has been used
by some investigators to calculate the number of DNA breaks
in samples (the actual ESCODD calibration curve was
documented in the final ESCODD report to the European
Union, but it was actually never reported in the published
papers from ESCODD). In the present study, a ‘common
calibration curve’ was obtained as the mean from all
laboratory-specific calibration curves. Figure 6 shows a com-
parison between the ESCODD curve and the common
calibration curve in this experiment (the mean level of DNA
damage in the coded samples is also depicted in the figure,
although they were not used in the common calibration curve).
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Fig. 4. Relationship between the level of DNA damage in coded cryopreserved
samples (analysed in each laboratory by its own comet assay protocol) and pre-
made slides (scored in each laboratory). The results represent laboratories that
analysed the level of DNA damage as %T (n 5 11) and arbitrary score (n 5 1,
range 0–100).
Table III. Assessment of the contribution of intra-laboratory (day-to-day variation) variation to the overall variation in the 12 participating laboratories
Laboratory Mean (SD) DNA damage in cryopreserved samplesa % of total variationb SDres
c
0 Gy 2.5 Gy 5 Gy 10 Gy Dose of
ionizing radiation
Intra-laboratory
variation
Residual
variation
1 11.2 (1.8) 34.7 (8.7) 55.7 (2.8) 73.7 (6.8) 91.5*** 0.1 8.4 7.4
2 9.7 (4.1) 30.5 (6.6) 51.0 (4.9) 72.4 (5.0) 93.7*** 0.1 6.2 6.2
3 0.9 (0.7) 8.7 (1.2) 15.7 (5.1) 34.5 (10.9) 86.1*** 5.7 8.2 4.0
4 0.5 (0.3) 26.3 (1.3) 51.0 (0.8) 83.3 (6.4) 97.7*** 0.3 2.0 4.6
5 6.1 (4.0) 14.0 (4.1) 20.1 (1.5) 41.8 (5.3) 93.1*** 0.5 6.4 3.6
6 2.0 (1.2) 23.8 (2.5) 44.4 (6.6) 80.4 (4.5) 98.3*** 0.4 1.3 3.4
7 3.4 (0.6) 23.5 (5.9) 41.0 (4.3) 65.9 (12.0) 92.8*** 3.2 4.0 4.9
8 6.5 (0.4) 27.5 (3.3) 50.3 (2.2) 81.7 (1.3) 98.8*** 0.2 1.0 5.2
9 1.0 (0.1) 2.6 (0.8) 4.9 (0.6) 9.7 (2.1) 93.7*** 0.1 6.2 0.9
10 16.2 (2.8) 30.7 (4.9) 43.8 (4.6) 73.0 (11.6) 94.9*** 0.2 4.9 5.1
11 2.2 15.3 18.6 37.8 97.4*** NC 2.6 2.3
12 4.5 29.3 51.6 82.8 99.3*** NC 0.7 3.0
aThe data are based on %T except for Laboratory 5, which measured DNA damage as visual score in arbitrary units (the data are the visual score in range of 0–100).
The calculations are based on data from the calibration curve samples that had been analysed in one (Laboratories 11 and 12), two (Laboratories 1, 9 and 10) and
three (Laboratories 2–8) separate experiments.
bAnalysed by GLM with the experiment and dose of ionizing radiation as categorical (random factor) and continuous variables, respectively. The data are reported as
the percentage of the total sum of squares. The statistical significance is as follows: ***P , 0.001. The GLM analysis was only used for data from laboratories that
analysed the calibration curve samples in two or three independent experiments. Data from laboratories that only reported results from one experiment were analysed
by linear regression and the percentage of variation corresponds to the regression coefficient (R2) of the regression analysis. For these data, the contribution of the
experiment was not calculated (NC). The term ‘intra-laboratory variation’ is the same as the day-to-day variation (variation from one experiment to another), whereas
the residual variation is the unexplained fraction of the total variation in the study.
cSDres is the SD of the residuals.
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The ESCODD calibration curve and the common calibration
curve are virtually the same.
Figure 7 depicts differences between results calculated by
the common calibration curve and results from the laboratory-
specific calibration curves (the data in figure 7 are the number
of lesions per 106 bp per Gy and the symbols indicate the dose
of ionizing radiation). It can be seen that there were larger
differences in the estimated level of lesions per 106 bp per Gy
when the data were calculated by the common calibration curve
than by the laboratory-specific calibration curves (Figure 7A).
Figure 7B outlines a Bland–Altman plot of the same data,
which is commonly used to assess whether the results from
different assays differ. The Bland–Altman plot (Figure 7B)
shows a systematic trend in the data with the difference
between the two ways of calibration becoming larger when the
value (lesions per 106 bp per Gy) is large.
Figure 8 shows inter-laboratory variation in the data
calculated as lesions per 106 bp per Gy. Most importantly, it
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Fig. 5. Lesions per 106 bp in the coded THP-1 samples. The samples labelled
A–D had been exposed to 1.5, 2.5, 5 and 7 Gy, respectively. The data are
calculated from %T (n 5 11) and visual score in arbitrary units (n 5 1, range
0–100) by use of the laboratory-specific calibration curves. Each point
represents the value from one laboratory. The CV represents the inter-
laboratory variation in DNA damage reported by the different laboratories.
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Fig 6. Calibration curve outline. Based on data from the coded samples (solid
circles), calibration curve samples (solid diamonds) and the ESCODD
calibration curve (open squares). The line represents the regression line
(R2 5 0.98). Based on the linear regression analysis, 1 unit (%T or arbitrary
score) corresponds to 0.1447 Gy equivalents. This corresponds to 0.042
lesions/109 dalton DNA or 0.0273 lesions/106 bp.
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Fig 7. (A) Comparison of DNA damage in terms of lesions per 106 bp per Gy
calculated using a common calibration curve or laboratory-specific calibration
curve. The common calibration curve was generated by first generating mean
calibration curves from each laboratory (the laboratories had analysed the
calibration samples on one to three different occasions) and then generating the
common calibration curve as the mean of different laboratories. This means
that the calibration curve from each laboratory contributed equally to the
common calibration curve. The variation in DNA damage calculated by the
common calibration curve is larger (SD 5 0.18) than the variation obtained
when using the laboratory-specific calibration curve (SD 5 0.08, P , 0.05,
Levene’s test). (B) Bland–Altman plot of the difference in lesions per 106 bp
per Gy calculated by the common calibration curve and laboratory-specific
calibration curves. It can be seen that there is a systematic trend toward larger
difference between the calibration curves as the level of DNA damage
increases, indicating that the two ways of calibration generate different results
that depend on the level of DNA damage in the sample. The symbols indicate
samples irradiated with 1.5 Gy (circles), 2.5 Gy (squares), 5 Gy (diamonds)
and 7 Gy (triangles).
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can be seen that using the laboratory-specific calibration curves
reduced the variation between the laboratories (CV 5 28%) as
compared with the common calibration curve (CV 5 47%,
P , 0.05, Levene’s test). Depicted in Figure 8 is an analysis
where we have calculated the level of DNA damage based on
tail moment as primary end point and laboratory-specific
calibration curves on tail moment. This analysis provide
the approximately same variation between laboratories
(CV 5 34%) as the data based on %T, which means that the
variation between laboratories did not get better (or worse)
using the tail moment as primary end point.
Assessment of components influencing the variation in DNA
damage
Based on the data reported in previous tables and figures, it is
possible to calculate the magnitude of variation between
different experiments in each laboratory (intra-laboratory
variation) and between laboratories (inter-laboratory variation)
and the magnitude of residual variation. Table III outlines the
calculation of the magnitude of the intra-laboratory variation,
which is identical to the inter-experimental variation. These
calculations were based on the data from the calibration curve
samples that were analysed on 1–3 separate days in the
laboratories. For each laboratory, we have calculated the
contribution of the dose of ionizing radiation, intra-laboratory
variation and residual variation (Table III). As can be seen,
both the intra-laboratory (inter-experiment) variation and the
residual variation are small compared with the variation related
to the dose of ionizing radiation. The residual variation is, on
average, higher than the intra-laboratory (inter-experiment)
variation, indicating that there is a large part of the variation
that cannot be explained by day-to-day variation.
Table IV outlines the results of statistical tests where the
dose of ionizing radiation, intra-laboratory variation, inter-
laboratory variation, primary comet assay end points (comput-
erized image analysis versus visual score) and residual
variation have been investigated. In all the tests, the dose of
ionizing radiation was the variable that explained the largest
part of the variation. The first row of Table IV shows the
analysis of the cryopreserved calibration curve samples. It can
be seen that intra-laboratory variation contributes very little to
the overall variation, which is in accordance with the results
obtained in Table III. In this analysis, 21.6% of the variation
was explained by differences between laboratories. The second
row of Table IV shows the results of the analysis of the pre-
made slides. Here, it is possible to compare the variation of the
laboratory procedures (staining and analysis) with the variation
related to the use of different end points. As can be seen, the
residual variation is almost the same in the first and second
rows in Table IV (SDres: 9.2 versus 11.1) and the contribution
of the dose of ionizing radiation was also very similar. The sum
of the inter-laboratory variation and residual variation in the
cryopreserved calibration curve samples was 33.9%; this is
only slightly higher than the same type of variation in the pre-
made slides (27.9%). The variation in the pre-made slides can
0.10 0.20 0.30 0.40 0.50
Lesions/106 bp per Gy
Type of sample CV
SampleB (2.5 Gy) 30
SampleC (5 Gy) 26
Mean (common) 47
SampleD (7 Gy) 19
Mean (lab-specific) 28
Mean (tail moment) 34
SampleA (1.5 Gy) 46
Fig. 8. Variation in the level of DNA damage per 106 bp per Gy in monocytic
THP-1 cells. The data in samples A–D represent the level of lesions per 106 bp
per Gy after adjustment of the primary comet assay end point (%T or visual
score) with the laboratory-specific calibration curves. For each laboratory, we
have calculated the mean level of lesions per 106 bp per Gy from the four
samples A–D, using the laboratory-specific calibration curve: the ‘mean (lab-
specific)’ row depicts this analysis (n5 12). The same adjustment and analysis
was carried out with the common calibration curve that was mean of all the
laboratory-specific calibration curves (n 5 12). The ‘mean (tail moment)’
shows the results of adjustment of the primary comet assay end point in terms
of the tail moment (n 5 9). It can be seen that the inter-laboratory variation is
lower when the data have been adjusted by the laboratory-specific calibration
curve as compared with the common calibration curve. However, adjustment
of primary comet assay end points in terms of either %T/visual score or tail
moment with the corresponding calibration curves yield low inter-laboratory
variation.
Table IV. Assessment of variables contributing to the overall variation in DNA damage in monocytic THP-1 cells exposed to ionizing radiation
Sample % of total variationa SDres
b
Dose of ionizing
radiation
Intra-laboratory
variation
Inter-laboratory
variation
Primary comet
assay end point
Residual
variation
Cryopreserved calibration
curve samplesc
66.0*** 0.1 21.6*** NC 12.3 9.2
Pre-made slides 68.7*** NC 8.9 3.4** 19.0 11.1
Coded samplesd 43.6*** NC 43.5*** NC 12.8 7.3
Coded samples (adjusted)e 77.1*** NC 16.3*** NC 6.6 3.8
aThe percentage of total variation has been calculated from the sum of squares in GLM analysis with the level of DNA damage as dependent variable; the dose of
ionizing radiation (continuous variable), laboratory (categorical random variable) and experiment (categorical random variable) were independent variables in the
GLM analysis. The contribution of the intra-laboratory variation (day-to-day variation) was assessed by analysis of the calibration curve samples that were analysed
on 1–3 different days of the analysis. Statistically significant effects are indicated as follows: **P , 0.01; ***P , 0.001; NC, not calculated.
bThe SD of the residuals (SDres) did not deviate from the normal distribution in any of the statistical tests (P . 0.05, Shapiro–Wilks test).
cThese are the calibration curve samples that have been analysed on one to three occasions by the 12 laboratories.
dThe cryopreserved coded samples had received 1.5, 2.5, 5 or 7 Gy of ionizing radiation and have been analysed on one occasion in each laboratory.
eThe values of DNA damage in the coded samples were adjusted according to the following equation: adjusted value 5 (value/slopelaboratory-specific calibration curve) 
Slopemean of all calibration curves.
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only originate from differences in the staining of slides and
analysis of the comet images. This implies that most of the
inter-laboratory variation originates from different procedures
in the staining and analysis of images. The contribution of the
dose of ionizing radiation and laboratory procedures to the
overall variation is shown in the third row of Table IV. These
samples were coded, in contrast to the calibration curve
samples (first row in Table IV), and there was a restricted dose
range of ionizing radiation. The coding probably explains why
the variation explained by the dose of ionizing radiation was
lower in this analysis. However, it should also be emphasized
that the residual variation was lower (SDres 5 7.3), which
means that there was less random variation in the analysis of
the coded samples compared with the uncoded cryopreserved
calibration curve samples. The fourth row of Table IV shows
the results of an analysis where the data analysed in the third
row were adjusted with the laboratory-specific calibration
curve; the residual variation (SDres) was reduced and the
variation explained by the dose of ionizing radiation increased.
This means that some of the random variation, embedded as
variation in the laboratory procedures in the analysis of the
third row in Table IV can be eliminated by correcting for
differences in laboratory procedures. Thus, a part of the
random variation can be eliminated by adjusting data using the
calibration curves (and thereby correcting for differences in
laboratory procedures). This finding is in accordance with the
assessment in Figure 8, which shows that the variation between
laboratories was reduced using laboratory-specific calibration
curves rather than a common calibration curve.
Discussion
This study shows that the comet assay is a reliable technique
for detecting DNA damage in biological samples in a dose-
dependent way. It is reassuring that all participating laborato-
ries were able to detect dose-dependent relationships in coded
samples. However, it is also clear that there is a large variation
in the values reported by different laboratories. This variation
arises from differences in comet assay protocols and systems of
analysis.
The results clearly document that the tail length as a primary
comet assay end point is rather poor because (i) there is a large
variation in non-irradiated samples, (ii) the dose–response
relationship saturates at low doses and (iii) the tail length does
not even show a dose-dependent relationship with ionizing
radiation. The differences in the tail length are probably the
results of different calibration of the software systems and
because some dyes may stain the comet tail better than others.
However, tail moment, %T and visual score displayed better
dose–response relationships with ionizing radiation, and
calibration using tail moment yielded the same inter-laboratory
variation as calibration using %T and visual score as primary
comet assay end points. It is not surprising that the tail moment
yields reliable results because several laboratories have
previously reported linear relationships between ionizing
radiation dose and comet tail moment (18–20). However, it
should still be kept in mind that the main criticism of the tail
moment as primary end point has been that it is difficult to
compare the values between laboratories, rather than its
reliability (7).
The values of DNA damage reported by different laborato-
ries had a large variation. In the pre-made slides, there was
a low inter-laboratory variation (determined as SDs) in the
unexposed samples but a large inter-laboratory variation with
irradiated cells (Table II). This pattern is expected when
analysis is by visual scoring because it is easier to discriminate
circular (Class 0) and highly damaged (Class 4) images than
those in the middle of the range. The same pattern was
observed for the pre-made slides analysed by %T, suggesting
that with image analysis, too, it is easier to measure nuclei
without migration than images having migration. Most
remarkable was the huge variation in %T in the pre-made
slides. The SDs in the pre-made slides analysed as %T
increased with increasing dose of ionizing radiation. The inter-
laboratory variation in %T originates most likely from different
settings of the image analysis systems or staining. However, it
should also be highlighted that the analysis of the coded
cryopreserved samples showed that the CV decreased with the
frequency of lesions per 106 bp (Figure 5). This is most easily
explained by the fact that the SDs remained relatively constant
in the different samples of irradiated cells after calibration of
the data, whereas the level of DNA damage increased with
increasing dose of ionizing radiation.
From the assessment of the variation (Table IV) it can be
inferred that the inter-laboratory variation is larger than the
residual variation and that there is very little intra-laboratory
variation. The study design used cannot discriminate between
the intra-laboratory variation and day-to-day variation (this
means that the variation attributed to the intra-laboratory
variation also includes a contribution from the day-to-day
variation and vice versa). The residual variation in normal
studies originates from variation within the same day (e.g.
variation in DNA damage between gels) and from day-to-day
variation (e.g. variation from one batch of analysis to another).
The analysis in Table IV indicates that day-to-day variation,
rather than variation within the same day, is the most important
contributor to the overall residual variation. This is in
accordance with an earlier assessment where it was found that
the assay variation (analysed in reference samples) was the
same as the residual variation in a regression model of
variables that contributed to the overall variation in DNA
damage in mononuclear blood cells (21). Although the source
of the residual variation is unknown, it can be speculated that
a part of it originates from variation in DNA damage between
gels. It has been argued that analysis of 25–50 images per gel is
sufficient to obtain a reliable measurement of the variability in
between gels, whereas scoring of 100 images from two to three
gels is adequate to obtain an accurate estimate of the DNA
damage in the sample (22).
Earlier studies on inter-investigator variation in visual score
showed that the variation (expressed as CV) in formamido-
pyrimidine DNA glycosylase (FPG)-sensitive sites could be
reduced from 59% to 39% in mononuclear blood cells using
investigator-specific calibration curves compared with a com-
mon calibration curve (8). Here, we show a similar reduction
in the CV, which was reduced from 47% to 28% by this
means (Figure 8). This adjustment of the data increased the
percentage of the overall variation that could be attributed to
the dose of ionizing radiation (Table IV). Overall, the data
indicate that it is possible to reduce inter-laboratory variation
by adjusting the primary comet assay data with the laboratory-
specific calibration curves. This is supported by results from
another study that showed that the CI was lower in
mononuclear blood cells when using investigator-specific
calibration curves than when using common calibration curves
[the estimated geometric means were 0.43 FPG-sensitive
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sites/106 bp (95% CI 0.14–1.27) versus 0.31 FPG-sensitive
sites/106 bp (95% CI 0.11–0.86)] (9).
The results outlined in Table III provide the possibility of
calculating the precision of DNA damage measurement by the
comet assay. A collective analysis of biomonitoring studies
indicated that the level of DNA damage in leukocytes from
healthy humans is about 10 units (arbitrary units on a scale of
0–100) when using %T and visual score as primary comet
assay end points (23). From the overall calibration curve in
Figure 6, we can estimate the average level of DNA damage in
human leukocytes to be 0.27 lesions/106 bp. The variation in
the measurement is outlined in Table III; as an example, we use
the residual variation from all the laboratories to calculate the
precision in the analysis (SDres, mean 5 4.2). This yields a 95%
CI of 0.21–0.34 lesions/106 bp for the mean level of 0.27
lesions/106 bp. In other words, a single analysis of the level of
DNA damage in a blood sample by the comet assay in a single
experiment is associated with a rather large variation. This
implies that to produce clinically meaningful results with the
comet assay requires that samples are obtained on more than
one occasion or that they are analysed on several occasions.
However, based on the assumption that a 5 5% (i.e.
probability of committing a type I error) and b 5 20%
(probability of committing a type II error), it would require
group sizes of 13 or 46 subjects to detect a 50% or 25%
difference in DNA damage between two groups, respectively.
A similar power calculation, encompassing inter-individual
variation, made more than a decade ago indicated that it would
require 18–50 subjects to detect a 50% difference between two
groups (24). It can thus be argued that the comet assay is
a suitable method for the detection of biological differences
between groups of subjects but that at the moment assay
variation precludes firm conclusions about the validity or
significance of values at the individual level. One can therefore
not extrapolate from single measurements of the comet assay
end points to draw conclusions concerning possible risk of
disease, although the validity of the results can be increased by
repeated measurements of samples from the same subject. The
precision can be increased by analysing more images per gel
and/or gels per sample for both sample and calibration curve
(reference standard) cells. However, this approach always has
the disadvantage that the adjustment of data is based on DNA
damage analysed in different gels. In any adjustment of data by
reference standards, the SD of the adjusted data is equal to the
sum of the SDs in the sample and reference standard. This
means that the adjustment of data is mainly successful if there
is a large day-to-day variation in the assay. In our study, we
found that the day-to-day variation was relatively small
indicating that the variation between experiments was not the
most important variable determining the overall variation. This
indicates that the variation arises because of variation in DNA
damage between gels; it should be possible to reduce variation
between gels by including a true internal standard in the same
gel as sample cells. Recent studies have shown that the
variation in DNA damage is indeed decreased using such an
internal standard in comet assay (25). The results reported here
encourage further progress towards establishing reference
standards, including internal standards, in the comet assay.
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